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Summary
Objective: To assess disability and health-related quality of life (HRQoL) of patients with knee or hip OA in primary care and to determine
factors associated with GPs’ opinion that their patients will need prosthetic replacement within 1 year after the consultation.
Methods: Design: A cross-sectional national survey.
Setting: Primary care in France.
Participants: 1471 GPs and 4183 patients with hip or knee OA.
Measures: Pain on an 11-point numeric scale (0e10), disability on the Western Ontario and MacMaster Universities Osteoarthritis Index
(WOMAC) (1e100) and Lequesne index (0e24), and quality of life on the Medical Outcomes Study 36-item Short Form (MOS SF-36; 0e100).
Results: We analyzed records of 4121 patients (2540 knee, 1581 hip OA). Patients with knee or hip OA exhibited high and similar levels of
pain (5.2 2.1 and 5.3 2.3) and disability (Lequesne score: 12.0 4.2 and 11.8 4.3; WOMAC score: 45.7 19.3 and 45.2 17.3) The
decrease in HRQoL was similar for patients with either location of the disease. GPs more often considered that their patients with hip OA
would need prosthetic replacement within 1 year (28.1%) than those with knee OA (15.8%). Most factors associated with GPs’ opinion
were identiﬁed for both locations of disease and were related to disability and pain levels.
Conclusions: In the primary care setting, patients with knee or hip OA have similar, high disability levels and substantially low HRQoL.
Patients’ disability seems to play a central role in GPs’ opinion of the need for their patients with either type of OA to undergo prosthetic
replacement within 1 year.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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1024lead to increased OA and, consequently, costs to treat
these patients. For example, the projections for 2030,
based on changes expected in the US population’s age
proﬁle, foresee an increase of about 80% and 85% of total
hip and knee replacements, respectively2. In France, the
entire hospital costs in 2001 for primary joint replacement
for hip and knee OA were 591 and 411 M euros, respec-
tively3. Hence, to forecast public health policies, disability
and HRQoL of this increasing population should be pre-
cisely assessed and integrated in treatment option
decisions.
However, disability and HRQoL are not usually recorded
in the primary care setting, largely because such recording
is time-consuming for general practitioners (GPs). There-
fore, data on disability and HRQoL for these patients are
largely extracted from secondary and tertiary care settings
or clinical trials, which do not always reﬂect ‘‘real-life’’ con-
ditions4,5. As well, data on levels of disability and HRQoL
in the general population of patients with hip and knee OA
are still scarce, even in industrialized countries6. Moreover,
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data, despite the publication of guidelines7. Reasons for
a GP to refer a patient to an orthopedic surgeon for total
joint arthroplasty are not standardized8e16 and differ among
countries and even within a country17e20. Finally, previous
reports suggest that GPs’ and orthopedic surgeons’ opin-
ions about the need for total joint replacement differ21,
and reasons to propose an arthroplasty might not always
be related to the patient’s clinical state22.
Although the ﬁnal decision of total joint arthroplasty
belongs to the surgeon, GPs’ opinions of the indication for
the arthroplasty largely inﬂuence patients. In France, to be
totally reimbursed for medical costs, patients must consult
a GP before seeing a specialist. Therefore, referral to a sur-
geon depends in part on a GP’s opinion. Determining
whether GPs’ opinions are related to clinically relevant
data (such as levels of pain and disability, and HRQoL) is
important to try to maximize management of patients with
hip and knee OA.
Our objectives were to assess disability and HRQoL in
a national sample of patients with hip and knee OA in the
primary care setting and to assess associations between
patients’ characteristics and GPs’ opinions about the need
to propose total joint replacement within 1 year after the
consultation.MethodsDESIGNWe conducted a cross-sectional survey among a national sample of gen-
eral practitioners (GPs).RECRUITMENT OF GPSIn June 2004, we invited 2300 GPs selected at random from a national da-
tabase according to a computerized allocation with geographic stratiﬁcation to
participate in the survey.RECRUITMENT OF PATIENTSBetween September 2004 and February 2005, each GP was to enroll the
ﬁrst three patients consulting for knee or hip OA. Patients were included if (1)
they were more than 45 years old, (2) the main motive for consulting was
knee or hip OA deﬁned by GPs, and (3) they had radiographic evidence of
hip or knee OA. Patients were excluded if they (1) had both hip and knee
OA; (2) had had surgery of the knee or hip; (3) had disabling co-morbidities;
(4) were unable to understand, speak, or write French; (5) or declined to
participate.ETHICAL APPROVALFrench bioethics legislation does not require consent from the hospital
ethics committee for this type of survey. The survey was conducted in com-
pliance with the protocol Good Clinical Practices and Declaration of Helsinki
principles. In accordance with the French national law, GPs and patients
gave their written agreement to participate after being informed of the survey
protocol.PHYSICIAN QUESTIONNAIREThe physician self-administered questionnaire contained questions about
demographics (age and sex) and professional practice (years and environ-
ment [rural/urban]). Before recording the patient’s Lequesne index score
(see following), the physician had to answer the question ‘‘Do you think
that this patient needs or will need a total hip/knee replacement? If yes,
within 1 year after this consultation?’’PATIENT QUESTIONNAIREFor each patient, the GP recorded the following: demographic data (age,
sex, sports activities [none, mild, intense]); main motive for consulting(treatment renewal, OA ﬂare-up, OA diagnosis); clinical data (weight, height,
body mass index, disease duration, OA location [hip/knee/one or both sides],
other OA location [spine, hands, feet], OA clinical symptoms [pain, stiffness,
joint swelling (yes/no)], number of days with pain during the previous month,
number of days with disability [deﬁned as difﬁculty performing daily tasks
(home, work, leisure, social)] during the previous month); treatments for
OA; cardiovascular, gastrointestinal, and mental (depression) co-morbidities;
and Lequesne index score23.
Before including patients, GPs received a letter explaining how to com-
plete these two questionnaires.
The patient self-administered questionnaire concerned family situation
(living alone, with a partner, with family, in an institution), housing (apart-
ment, house, presence of an elevator, rural/urban area, moved because of
OA, house adaptation because of OA), educational level (primary school,
high school, post-graduate), work situation (retired, working, not working, un-
employed, disabled status), pain (on an 11-point numeric scale, from 0, no
pain, to 10, maximal pain), patients’ perceived disability (on a 6-point Likert
scale, from not at all, to unbearable), functional status (on the function sub-
scale of the Western Ontario and MacMaster Universities Osteoarthritis In-
dex [WOMAC] for hip24 and modiﬁed WOMAC for knee25,26, from 0, no
disability, to 100, maximal disability), and HRQoL (on the Medical
Outcomes Study 36-item Short Form [SF-36])27. This questionnaire was
completed by the patient alone after consultation with the GP and super-
vised by the GP to avoid missing data.STATISTICAL ANALYSISData analysis involved use of SAS 8.2 software (SAS institute Inc, Cary,
NC, USA). Quantitative variables are described with means standard
deviations (SD) and qualitative variables with raw data and percentages.
In univariate analysis, means were compared with use of the Wilcoxon
rank sum test and percentages were compared with use of the c2 test.
A P value< 0.05 was considered statistically signiﬁcant.
Severity thresholds for the Lequesne index and the WOMAC were calcu-
lated using the Youden method. For this purpose severity was deﬁned as an-
swering important, very important, or unbearable to the question about
patients’ perceived disability.
Stepwise logistic regression analysis was performed to determine
whether GP’s opinions about the need for their patients to undergo total
hip/knee replacement within 1 year were associated with patients’ or
GPs’ characteristics selected from univariate analysis. Factors included
in the multivariate analysis were those with statistically signiﬁcant differ-
ence between groups (P< 0.05) on univariate analysis. We did not in-
clude factors without statistically signiﬁcant difference but, rather,
included those with P< 0.2 because of the high number of factors. How-
ever, factors considered clinically pertinent, such as gender, age, BMI,
main reason for consulting, and OA location, were entered (forced) in
the model without considering the statistical signiﬁcance of the differ-
ences observed between groups on univariate analysis. Multicolinearity
among the variables can hinder the interpretation of the results. A step-
wise selection allowed for identifying the independently associated vari-
ables (with levels to enter and to stay in the model of P< 0.10 and
0.15, respectively). For each of the selected covariates, odds ratios
(ORs) with 95% conﬁdence intervals (CIs) were calculated.
An internal validation of the model was performed using the bootstrap re-
sampling technique28. The model was applied to 1000 replicated bootstrap
samples. For each bootstrap sample, a stepwise logistic regression was per-
formed with the variables entered in the analysis performed in the original
sample. For each variable the frequency of being in the ﬁnal model was cal-
culated. Finally, we checked whether variables most often selected in the
model were the ones selected in the original model.ResultsPHYSICIAN CHARACTERISTICSA total of 1471 GPs (64% of GPs invited to participate)
enrolled at least one patient. Mean age was 49 years
old, and most physicians were male (85%) and working
in a rural environment (59%). Our sample differed slightly
from the general population of French GPs (national regis-
ter) by involving more men (85.0% vs 71.3% in the national
register) who were older (49 years vs 47 years in the
national register) and probably more likely to work in a rural
environment (no reliable data available because of differ-
ent deﬁnitions of rural/urban). The mean number of pa-
tients included by GPs was 2.81 (95% CI: 2.78e2.84,
median 3.0).
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Demographic and clinical characteristics of patients with knee or
hip OA
Whole sample
(N¼ 4121)
Knee OA
(N¼ 2540)
Hip OA
(N¼ 1581)
Age (meanSD),
years
67 10 67 10 67 10
Age> 65 years (yes) 2510 (61%) 1539 (61%) 971 (61%)
Sex (M) 1703 (42%) 994 (40%) 709 (45%)
Living situation
Living alone 1203 (29%) 750 (30%) 453 (28%)
Living with a
partner
2467 (60%) 1487 (59%) 980 (62%)
Living with family 419 (10%) 275 (11%) 144 (9%)
Living in institution 39 (1%) 25 (1%) 14 (1%)
Education level
Primary school 2352 (57%) 1483 (59%) 869 (55%)
High school 1274 (31%) 773 (31%) 501 (32%)
Post-graduate 477 (12%) 268 (10%) 209 (13%)
Work status
Working 749 (18%) 487 (19%) 262 (17%)Patients’ demographic characteristics and clinical data
according to OA location are shown on Table I. Records
of 4121 patients (98.7% of patients included) were ana-
lyzed (2540 knee, 1581 hip OA). Geographic location of pa-
tients followed that of the general population (Fig. 1). More
than half of the patients (57%) visited their GP for treatment
renewal, 40% for OA ﬂare-up, and almost 3% for the diag-
nosis of OA. Patients with either knee or hip OA showed
high and similar levels of pain (5.2 2.1 and 5.3 2.3)
and disability (Lequesne index: 12.0 4.2 and 11.8 4.3
and WOMAC: 45.7 19.3 and 45.2 17.3). For hip OA,
severity thresholds were 13 for the Lequesne index and
52 for the WOMAC. For knee OA, they were 12 for the
Lequesne index and 49 for the WOMAC. Patients with
either location of OA showed similar decreased HRQoL
as compared with the French general population (SF-36
physical component score (PCS): 32.0 8.4 and
31.8 8.4 and mental component score (MCS): 47.1
10.9 and 46.8 11.1 for patients with knee and hip OA,
respectively) (Table II).Retired 2886 (70%) 1760 (69%) 1126 (71%)
Housewife, other
homemaker
357 (9%) 213 (8%) 144 (9%)
Unemployed 58 (1%) 38 (2%) 20 (1%)
Disabled status 67 (2%) 36 (2%) 31 (2%)
Environment (rural) 1678 (41%) 1044 (42%) 634 (40%)DEMOGRAPHIC AND CLINICAL DATA OF PATIENTS WITH OR
WITHOUT GPS’ INDICATION FOR PROSTHETIC REPLACEMENT
WITHIN 1 YEAR AND FACTORS ASSOCIATED WITH THE NEED
FOR TOTAL JOINT REPLACEMENT
Housing
Moving because
of OA (yes)
145 (4%) 95 (4%) 50 (3%)
House adaptation
because of OA (yes)
408 (10%) 247 (10%) 161 (10%)
OA duration
(meanSD), years
5.7 4.9 5.9 5.0 5.4 4.8
Body mass index (kg/m2) 27.7 4.6 28.2 4.8 27.0 4.0
Main reason for consulting GP
Treatment renewal 2362 (57%) 1430 (56%) 932 (59%)
OA ﬂare-up 1650 (40%) 1034 (41%) 616 (38%)
OA diagnosis 121 (3%) 68 (3%) 43 (3%)
Sports activities
None 2518 (61%) 1534 (61%) 984 (62%)
Occasional 1476 (36%) 922 (36%) 554 (35%)
Usual 118 (3%) 73 (3%) 45 (3%)
Medications
Analgesics (yes) 3317 (84%) 2014 (84%) 1303 (85%)
NSAIDs (yes) 3120 (79%) 1876 (78%) 1244 (81%)
SYSADOA (yes) 1725 (44%) 1086 (45%) 639 (42%)
Pain level
(meanSD) (0e10)
5.2 2.0 5.2 2.1 5.3 2.3
Number of days
with pain during
the previous month
17.4 9.1 17.2 8.9 17.7 9.2
Number of days
with disability during
the previous month
18.2 9.3 18.1 9.2 18.5 9.4
Self-rated disability
None 31 (1%) 18 (1%) 13 (1%)
Weak 469 (12%) 266 (11%) 203 (13%)
Moderate 1567 (39%) 957 (39%) 610 (39%)
Severe 1365 (34%) 869 (35%) 496 (32%)
Extremely severe 556 (14%) 347 (14%) 209 (14%)
Unbearable 49 (1%) 28 (1%) 21 (1%)
Lequesne score
(0e24)
11.9 4.3 12.0 4.2 11.8 4.3
WOMAC score
(0e100)
45.6 18.8 45.7 19.3 45.2 17.3
Values are number of patients (percentages); NSAID: nonsteroi-
dal anti-inﬂammatory drug; SYSADOA: slow-acting drug for OA.Demographic characteristics and clinical data of patients
with or without GPs’ indication for prosthetic replacement
within 1 year according to OA location are shown in
Table III. Patients with a GP’s indication for prosthetic re-
placement within 1 year were more likely to have hip than
knee OA (28.1% and 15.8%, respectively; OR: 2.1, 95%
CI: 1.8e2.4) and had higher pain, disability, and decreased
HRQoL levels than patients without a GP’s indication (Table
III). They also were more likely to have a female GP (17.4%
and 14.0%, respectively, P¼ 0.01).
We also compared GPs’ indication for prosthetic replace-
ment for hip and knee OA because we wanted to know
whether the factors for replacement with each OA type
(for instance pain and disability) were the same and
clinically relevant. Among patients with an indication for
joint replacement, patients with knee OA were more likely
to be female, be older, have a lower education level, have
longer duration of OA symptoms, report fewer days with
pain or disability during the previous month, and have
a higher Lequesne score than those with hip OA, with no
difference in other assessments of pain, disability and
HRQoL.
On univariate analysis, as compared to patients without
an indication for total hip replacement within 1 year, those
with an indication more likely lived in a rural environment
(as did their GP), were male, were older, had a higher
body mass index and fewer physical activities, had a lower
level of education and less often occupational activities,
had spinal OA with more joint stiffness and more often
took medication for OA, were more often depressed,
had hypertension, considered their disability as important,
had more days with pain and disability during the previ-
ous month, had higher scores for disability (Lequesne
and WOMAC) and lower scores for HRQoL (PCS and
MCS) (Fig. 1), and were less likely to have had a
stroke.
As compared to patients without an indication for total
knee replacement within 1 year, those with an indication
more likely lived in a rural environment (as did their GP);
Fig. 1. Box plots (25th percentile) of disability and health-related quality-of-life scores according to OA location and indication for prosthetic
replacement (PR).
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and fewer physical activities; had a lower level of education
and less often occupational activities; had hand, foot and
spinal OA with more joint stiffness or swelling; more often
took medication for OA; had angina or infarction; had hyper-
tension, considered their disability important; had more
days with pain and disability during the previous month;
had higher scores for disability (Lequesne and WOMAC)
and lower scores for HRQoL (PCS and MCS) (Fig. 1);
and were less likely to have had a stroke.
Results of multivariate analysis are shown in Table IV.
Factors associated with an increased risk of undergoing
total joint replacement were common for those with hip
and knee OA and related to disability or pain levels, except
for being a male, which was a risk factor for only patients
with hip OA. Factors selected from the original logistic
regression were those most often observed in bootstrap
analysis (Table IV).Table I
HRQoL as assessed by the SF
Whole sample (N¼ 4121) Knee OA
Physical functioning 39.6 24.5 40.0
Physical role 31.8 37.1 32.9
Bodily pain 39.6 15.7 39.6
General health perception 48.7 18.4 48.7
Mental health 60.9 18.8 61.1
Emotional role 55.2 43.0 55.8
Vitality 51.4 18.2 51.7
Social functioning 60.5 23.0 61.2
PCS 31.9 8.4 32.0
MCS 47.0 11.0 47.1
*Leple`ge A, Ecosse E, Pouchot J, Coste J, Perneger T. Le questionna
scores. Paris: Editions Estem, 2001, 156 pp.DiscussionMAIN RESULTSPatients consulting their GPs for hip or knee OA have
similar levels of pain, disability, and HRQoL. Patients’
pain and disability levels seem to play a central role in
GPs’ opinion of the need for the patients to undergo pros-
thetic replacement within 1 year of consultation, regardless
of location of OA.
Our results suggest that the burden of hip and knee OA in
primary care is substantial and similar. We report, for the
ﬁrst time, similar levels of disability and low HRQoL among
patients with hip or knee OA consulting in primary care. A
Dutch survey conducted in primary care reported patients
with hip complaints having higher levels of disability and de-
creased HRQoL than those with knee complaints6. These
discrepancies may be due to differences in the population
studied e more heterogeneous in the Dutch survey,I
-36 in knee and hip OA
(N¼ 2540) Hip OA (N¼ 1581) French general
population* (N¼ 3656)
 24.5 39.0 24.6 83.0 23.8
 37.5 30.1 36.5 77.9 35.3
 15.6 39.7 15.8 70.2 23.4
 18.3 48.6 18.6 70.1 21.4
 18.8 60.6 18.9 57.0 21.1
 43.1 54.3 42.9 83.6 23.0
 18.2 51.4 18.2 83.1 23.6
 22.7 59.4 23.6 75.2 17.6
 8.4 31.8 8.4
 10.9 46.8 11.1
ire MOS SF-36: Manuel de l’utilisateur et guide d’interpre´tation des
Table III
Demographic and clinical characteristics of patients without and with GPs’ indication for prosthetic replacement within 1 year
No indication
(whole sample)
(N¼ 3272)
Indication
(whole sample)
(N¼ 849)
c2 or Wilcoxon P
value (indication
vs no indication)
Indication
knee
OA (N¼ 401)
Indication
hip OA
(N¼ 448)
c2 or Wilcoxon
P value
(knee vs hip)
Age (meanSD),
years
67 9 70 9 0.0001 71 9 68 9 0.0002
Age> 65 years 1905 (53%) 605 (72%) 0.001 303 (76%) 302 (68%) 0.01
Sex (M) 1338 (41%) 365 (43%) 0.3 149 (38%) 216 (48%) 0.002
Living situation 0.027 0.86
Living alone 1957 (60%) 257 (30%) 125 (31%) 132 (29%)
Living with a partner 946 (28%) 510 (60%) 238 (60%) 272 (61%)
Living with family 351 (11%) 68 (8%) 30 (7%) 38 (9%)
Living in institution 26 (1%) 13 (2%) 7 (2%) 6 (1%)
Education level 0.001 0.01
Primary school 1815 (56%) 537 (64%) 270 (68%) 267 (60%)
High school 1037 (32%) 237 (28%) 109(27%) 128 (29%)
Post-graduate 408 (12%) 69 (8%) 22 (5%) 47 (11%)
Work status 0.001
Work during
the last year (no)
2410 (77%) 712 (87%) 342 (89%) 370 (85%) 0.18
Environment (rural) 1278 (39%) 400 (47%) 0.001 196 (49%) 204 (46%) 0.28
OA duration
(meanSD), years
5.5 5.0 6.0 4.5 0.01 6.0 5.0 5.5 4.7 0.001
Body mass index (kg/m2) 27.5 4.3 28.1 4.8 0.03 28.9 5.2 27.4 4.2 0.05
Main reason
for consulting GP
0.06 0.51
Treatment renewal 1880 (57%) 482 (57%) 235 (59%) 247 (55%)
OA ﬂare-up 1299 (39% 354 (42%) 113(41%) 191 (43%)
OA diagnosis 100 (3%) 11 (1%) 1(0%) 1 (0%)
Sports activities 0.001 0.61
None 1938 (59%) 580 (69%) 280 (70%) 300 (67%)
Occasional 103 ( 3%) 250 (29%) 113 (28%) 137 (31%)
Usual 1226 (38%) 15 (2%) 6 (2%) 9 (2%)
Medications
Analgesics (yes) 2575 (78%) 742 (87%) 0.001 349 (87%) 393 (88%) 0.76
NSAIDs (yes) 2401 (73%) 719 (84%) 0.001 337 (84%) 382 (84%) 0.81
SYSADOA (yes) 1381 (42%) 344 (41%) 0.42 169 (42%) 175 (39%) 0.36
Pain level
(meanSD) (0e10)
5.0 2.0 6.3 1.7 0.0001 6.4 1.8 6.3 1.7 0.53
Number of days
with pain during
the previous month
15.9 8.7 23.1 8.0 0.001 22.6 8.1 23.7 7.8 0.04
Number of days
with disability during
the previous month
16.7 9.0 24.2 7.8 0.001 23.9 8.1 24.5 7.7 0.04
Self-rated disability 0.001 0.262
None/weak/moderate 1849 (58%) 218 (26%) 96 (24%) 122(28%)
Severe/extremely
severe/unbearable
1355 (42%) 615 (74%) 298 (76%) 317 (72%)
Lequesne score (0e24) 11.2 4.1 14.9 3.6 0.001 15.3 3.5 14.5 3.7 0.006
WOMAC score (0e100) 43.2 18.6 54.8 15.2 0.001 55.3 16.3 54.3 14.2 0.41
SF-36 score
Physical functioning 43.2 24.2 25.9 20.7 0.0001 25.3 20.2 26.5 21.0 0.49
Physical role 35.1 38.0 17.8 29.7 0.0001 18.7 30.0 17.0 29.4 0.36
Bodily pain 41.7 15.4 31.5 13.8 0.0001 31.1 14.5 31.9 13.2 0.24
General health perception 49.8 18.1 44.3 18.7 0.0001 43.9 18.6 44.7 18.9 0.66
Mental health 61.9 18.5 57.0 19.4 0.0001 57.3 19.7 56.7 19.2 0.63
Emotional role 57.9 47.2 44.8 43.1 0.0001 45.3 43.0 44.3 43.3 0.71
Vitality 52.7 17.9 46.0 18.3 0.0001 46.2 18.6 45.8 18.1 0.80
Social functioning 62.8 22.3 51.5 23.6 0.0001 52.7 23.4 50.4 23.6 0.18
PCS 33.1 8.4 27.5 6.8 0.01 27.2 6.8 27.6 6.7 0.39
MCS 47.4 10.8 45.2 11.6 0.01 45.6 11.9 44.8 11.4 0.34
Values are number of patients (percentages); SYSADOA: slow-acting drug for OA; NSAID: nonsteroidal anti-inﬂammatory drug.
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with hip or knee OA. As well, the inclusion criterion in the
Dutch survey was new episodes of complaints but in our
survey, consulting for OA.
Substantial decreases in HRQoL have been previously
reported in hip and knee OA29. Results of a Chinese surveyconducted in primary care suggested that patients
perceived knee OA to be more disabling than hypertension,
diabetes mellitus, and heart disease30, whereas doctors
considered the three latter conditions as the most important
chronic conditions31. This discrepancy between how
patients and doctors deﬁne the importance of an illness
Table IV
Factors associated with GPs’ indication for patients to undergo total joint replacement within 1 year after consultation in multivariate analysis
Factors Both OA
locations
[OR (95% CI)]
Frequency
of variable
selection
(bootstrap
analysis,
1000 sample)
(%)
Hip OA
[OR (95% CI)]
Frequency
of variable
selection
(bootstrap
analysis,
1000 sample)
(%)
Knee OA
[OR (95% CI)]
Frequency
of variable
selection
(bootstrap
analysis,
1000 sample)
(%)
Lequesne score
(>severity threshold)
2.40 (1.90e3.04) 100 2.62 (1.83e3.75) 100 2.36 (1.71e1.25) 100
Number of days with pain
per month (10 days)
1.71 (1.43e2.04) 100 1.95 (1.50e2.55) 100 1.39(1.10e1.75) 80
Number of days with disability
per month (10 days)
1.40 (1.17e1.67) 95 1.39 (1.07e1.82) 64 1.50 (1.19e1.91) 88
Patients’ opinion of their
disability (moderate/severe)
1.65 (1.30e2.11) 98 1.74 (1.20e2.51) 73 1.57 (1.013e2.20) 77
SF-36 PCS 0.97 (0.95e0.99 90 0.96 (0.94e0.99) 74 0.97 (0.95e0.99) 53
Rural environment 1.39 (1.13e1.70) 88 1.49 (1.09e2.04) 68 1.43 (1.09e1.87) 71
Age 65 1.43 (1.10e1.86) 79 1.51 (1.07e2.11) 46 1.87 (1.36e2.56) 87
Gender (male) 1.67 (1.35e2.06) 98 1.92 (1.39e2.65) 96 1.18 (0.71e1.47) 0
Hip OA 2.74 (2.18e3.45) 100 NA NA NA NA
Treatment for OA (yes) 2.77 (1.33e5.77) 82 2.89 (0.92e9.04) 45 2.22 (0.85e5.82) 42
NA: not applicable.
1029Osteoarthritis and Cartilage Vol. 16, No. 9associated with substantial decreases in HRQoL and the
ability to perform daily activities in knee OA we and others
report should lead to a paradigmal shift toward a more
patient-centered approach in hip and knee OA32.
GPs more often considered that patients with hip than
knee OA would need total joint replacement within 1 year
after consultation or sooner or later. GPs might believe
knee replacement results in more disability than hip
replacement. However, data on the comparison between
hip and knee arthroplasty are inconsistent. Nevertheless,
prospective studies33e41 reported greater postoperative im-
provement in pain relief and physical function for subjects
with hip than knee arthroplasty. However, results of a recent
study suggested that the level of mobility is similar between
people with recent knee arthroplasty and those with recent
hip arthroplasty42. Moreover, people with recent knee
arthroplasty reported a lower level of disability than the
other group for washing and bending forward.
Therefore, that patients with knee OA whose GPs
consider as needing total joint replacement within 1 year
of consultation tended to be older with longer OA duration
than patients with hip OA is not surprising. However, both
groups had the same level of pain and low HRQoL. Con-
cerning disability, knee and hip OA groups needing total
joint replacement within 1 year differed in Lequesne score
but not WOMAC or physical functioning score of the SF-
36. The Lequesne score was signiﬁcantly different between
the groups (0.8 on a 24-point scale) but this difference is
probably not clinically relevant.
Patients with knee or hip OA whose GPs considered as
needing total joint replacement within 1 year had higher
pain and disability levels and low HRQoL than patients with-
out an indication for replacement, and factors associated
with GPs’ opinion mainly concerned pain and disability
levels. Our results differ from those of a large Canadian
population-based survey suggesting no signiﬁcant differ-
ence in pain and function between patients with and without
a recommendation for joint replacement22. Although severe
pain and disability are probably not the only factors deter-
mining who undergoes total joint replacement43,44 and
personal meanings are probably of importance45, GPs
probably consider patients with more pain and disability tobe more likely to undergo total joint replacement within 1
year.LIMITATIONSAlthough we tried to ensure a national representation of
GPs, our sample differed slightly from the general popula-
tion of French GPs (national register). This limitation has
already been observed in previous national surveys on
acute and subacute low back pain conducted in primary
and secondary care settings46,47. Our response rate was
low but was higher than that previously reported for this
kind of survey in this setting in France46. Therefore, we can-
not exclude that our patient sample differs slightly from the
knee and hip OA population consulting GPs in France, and
these limitations might bias the generalizability of our re-
sults. We chose radiological evidence of OA as an inclusion
criterion because we wanted to maximize the probability
that hip or knee pain was related with OA. By making this
choice, we probably missed a few patients with a very early
stage of OA.
We recorded GPs’ perceptions of the need for prosthetic
replacement surgery, and these statements are not ac-
tions. We cannot exclude that, outside the context of the
survey, GPs may not consider referring their patient to
surgeons.
We did not interview GPs about the potential inﬂuence of
the health care system on their opinion for the indication of
prosthetic replacement. However, France does not have
waiting lists or no current health care plan for total joint
replacement and the cost of the intervention for patients is
minimal. Therefore, the French health care system likely
has no or only a marginal inﬂuence on GPs’ opinions;
however, this may be one reason why our results probably
cannot be generalized to other countries with more restrict-
ing health care systems.
The completion of questionnaires by the patient after their
consultation with the primary care physician may have re-
sulted in a potential bias, since the patient’s responses
may have been inﬂuenced by the physician’s opinion of
the severity of disease. We cannot exclude that this bias
might result in the ﬁnding of an association between the
1030 I. Boutron et al.: Disability and quality of life of patients with knee or hip osteoarthritisGP’s recommendation of joint replacement surgery within
a year and the patient’s perceived disability.
Finally, ours is a cross-sectional study, so we do not have
any data on the chronology of the occurrence of the factors
investigated; therefore, we can make statements only about
associations but cannot assume causation. Data from
observational studies should be viewed with caution and
should not be extrapolated.
In conclusion, patients with knee or hip OA in the primary
care setting have similar high disability levels and substan-
tially low HRQoL. GPs’ opinion of the need for patients with
either location of OA to undergo prosthetic replacement
within 1 year seems to be mainly inﬂuenced by clinical
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